GSK hits back at Avandia safety probe
February 25, 2010Sales and Marketing Avandia, diabetes
GlaxoSmithKline has hit back at allegations from US Senators that its diabetes drug Avandia raises the risk of heart attacks, …
Digital Pharma: Novartis tells cystic fibrosis stories
February 25, 2010Medical Communications Novartis, cystic fibrosis, digi, digi pharma, social media
Novartis has launched a new disease awareness campaign for cystic fibrosis that blurs the lines between fact and fiction. Its …
Avastin study in ovarian cancer meets primary endpoint
February 25, 2010Research and Development Cancer, avastin, ovarian
Preliminary results from a trial of Roche’s Avastin in advanced ovarian cancer suggest that the drug lengthens progression-free survival when …
Sanofi’s breast cancer candidate tipped for future success
February 25, 2010Research and Development, Sales and Marketing BSI-201, Sanofi-Aventis, breast cancer
A Sanofi-Aventis drug currently in phase III has been predicted as a future blockbuster in breast cancer treatment. Sanofi’s BSI-201 …
GSK’s Deidre Connelly named Woman of the Year
February 25, 2010Sales and Marketing GlaxoSmithKline, HBA, appointment, sales and marketing
The Healthcare Businesswomen’s Association has named Deidre Connelly its 2010 Woman of the Year. Connelly is president of North America …
CME Spotlight: Restoring confidence
February 25, 2010Medical Communications CME, CME Spotlight, Eugene Pozniak, ethics
As John Maynard Keynes said: “The long term doesn’t matter very much, because in the long run, we are all …
New starters at Double Helix
February 25, 2010Sales and Marketing Double Helix, appointment, sales and marketing
Healthcare consultancy Double Helix has appointed Amanda Siebols (pictured) as a research consultant and Ioanna Maraki as a research executive. …
Obama ‘closer than ever’ to health reform
February 25, 2010Sales and Marketing Obama, US healthcare
The continuing showdown over health insurance reform in the US reaches its next potential flashpoint today (Thursday) with what is …
Merck KGaA posts modest revenue increase
February 24, 20102009 financials, Erbitux, Merck KGaA, Merck Serono, Rebif
German pharma company Merck has posted a modest rise in revenue amidst strong pharma growth. Revenues increased 2.1% to 7.7 …
Sudler & Hennessey promotes Max Jackson
February 24, 2010Medical Communications Sudler & Hennessey, appointment, medical communications
Max Jackson has been promoted to chief executive, EMEA and APAC, at advertising agency Sudler & Hennessey (S&H). In his …
Avastin fails in phase III study
February 24, 2010Research and Development Roche, avastin, gastric cancer, stomach cancer
Roche’s Avastin does not help patients with a severe form of stomach cancer to live longer, according to the results …
NICE approves Yondelis
February 24, 2010Sales and Marketing NICE, PharmaMar, Yondelis
Cancer drug Yondelis has been approved by NICE for use on the NHS, but only after the manufacturer offered to …
NHS Alliance finds its own third way
February 24, 2010NHS, NHS Alliance
The NHS Alliance has proposed a new business model for the NHS that would draw on the health service’s founding …
Methylene blue poised to move into the clinic
February 24, 2010Manufacturing and Production, Research and Development Novasep, ProveBlue, Provepharm, malaria
A new purer form of the reagent methylene blue could take the compound out of the testing laboratory and into …
New role for McCann’s Andrew Berrie
February 24, 2010Medical Communications McCann Healthcare, appointment, medical communications
Andrew Berrie’s roll within McCann Healthcare Worldwide’s Medical Communications arm has been enlarged. His remit will now also include being …
Predatory Icahn moves in on weakened Genzyme
February 23, 2010Research and Development, Sales and Marketing Gaucher, Genzyme, Icahn
Corporate raider Carl Icahn has made a bid to gain control of beleaguered Genzyme as it struggles to overcome major …
Reports raise fresh Avandia safety questions
February 23, 2010Research and Development, Sales and Marketing Avandia, GlaxoSmithKline, diabetes
GlaxoSmithKline’s troubled diabetes drug Avandia has been hit by fresh reports from the US that it increases the risk of …
Baroness Thornton joins the Department of Health
February 23, 2010DH, UK, appointment
Baroness Thornton has been appointed parliamentary under-secretary of state at the Department of Health. Prior to this she was government …
Pfizer, Lilly and Merck partner for cancer research
February 23, 2010Research and Development Asia, Cancer, developing world, em, emerging markets
Three pharma companies have formed a not-for-profit organisation, the Asian Cancer Research Group (ACRG), to boost work on treating common …
Digital Pharma: Searching for clinical trials
February 23, 2010Research and Development CRO, TrialReach, digi, digital pharma, digital pharma research, digital research, patient recruitment
A new clinical trials search and referral engine has launched to help patients who are considering taking part in a …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
